Kevin Latinis
- Rheumatology top 0.2%
- Immunology top 1%
- Radiology, Nuclear Medicine and Imaging top 1%
- Molecular Biology top 10%
- Nephrology top 1%
- Co-authors
- Gary A. KoretzkyDavid ZhangPaul BrunettaJoseph C. ShanahanLyse A. NorianTammy O. UtsetDaniel J. WallaceJay Garg
- Topics
- CAR-T cell therapy research (6 papers)Systemic Lupus Erythematosus Research (6 papers)T-cell and B-cell Immunology (6 papers)
- Cited by
- RheumatologyImmunologyNephrology
- Journals
- Journal of Biological ChemistryThe Journal of Experimental MedicineThe Journal of Immunology
- Partner nations
- United StatesMexicoUnited Kingdom
In The Last Decade
Kevin Latinis
21 papers receiving 3.9k citations
Hit Papers
Peers
Comparison fields: 5 of 97
- Rheumatology 2.1k
- Immunology 1.9k
- Radiology, Nuclear Medicine and Imaging 1.3k
- Molecular Biology 775
- Nephrology 456
Countries citing papers authored by Kevin Latinis
This map shows the geographic impact of Kevin Latinis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin Latinis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin Latinis more than expected).
Fields of papers citing papers by Kevin Latinis
This network shows the impact of papers produced by Kevin Latinis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin Latinis. The network helps show where Kevin Latinis may publish in the future.
Co-authorship network of co-authors of Kevin Latinis
This figure shows the co-authorship network connecting the top 25 collaborators of Kevin Latinis. A scholar is included among the top collaborators of Kevin Latinis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kevin Latinis. Kevin Latinis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 55 | |
| 2 | 311 | |
| 3 | 66 | |
| 4 | Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: The lupus nephritis assessment with rituximab studybreakdown → | 972 |
| 5 | 253 | |
| 6 | 10 | |
| 7 | Efficacy and safety of rituximab in moderately‐to‐severely active systemic lupus erythematosus: The randomized, double‐blind, phase ii/iii systemic lupus erythematosus evaluation of rituximab trialbreakdown → | 972 |
| 8 | 192 | |
| 9 | 9 | |
| 10 | 103 | |
| 11 | 169 | |
| 12 | 59 | |
| 13 | 16 | |
| 14 | 176 | |
| 15 | 218 | |
| 16 | 3 | |
| 17 | 26 | |
| 18 | A newly identified response element in the CD95 ligand promoter contributes to optimal inducibility in activated T lymphocytes. | 27 |
| 19 | 197 | |
| 20 | 152 |
About Kevin Latinis
Kevin Latinis is a scholar working on Immunology, Rheumatology and Oncology, having authored 21 papers that have together received 4.0k indexed citations. Recurring topics across this work include CAR-T cell therapy research (6 papers), Systemic Lupus Erythematosus Research (6 papers) and T-cell and B-cell Immunology (6 papers). The work is most often cited by research in Rheumatology (2.1k citations), Immunology (1.9k citations) and Nephrology (456 citations). Kevin Latinis has collaborated with scholars based in United States, Mexico and United Kingdom. Frequent co-authors include Gary A. Koretzky, David Zhang, Paul Brunetta, Joseph C. Shanahan, Lyse A. Norian, Tammy O. Utset, Daniel J. Wallace, Jay Garg, Hsin‐Ju Hsieh and R. John Looney. Their work appears in journals such as Journal of Biological Chemistry, The Journal of Experimental Medicine and The Journal of Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.